PRIMO 2023 | Treatment options for small cell prostate cancer

Ravi Madan, MD, National Cancer Institute, Bethesda, MD, describes current treatment strategies for small cell prostate cancer, a rare form of prostate cancer. Based on treatment guidelines for small cell lung cancer, patients with small cell prostate cancer is typically given platinum-etoposide doublet chemotherapy, or immune checkpoint inhibitors. Questions regarding second-line therapy remain, however, unanswered. This interview took place at the Practical Recommendations in Immuno and Molecular Oncology (PRIMO) 2023 Congress in Honolulu, HI.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.